Pamela H. Gulden

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Jonathan Skipper, Ronald C. Hendrickson, Pamela H. Gulden et al. · The Journal of Experimental Medicine · 1996 · 409 citations · Full text

Immunology, Immunoediting, Immunodominance +18

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

Alex Y. Huang, Pamela H. Gulden, Amina S. Woods et al. · Proceedings of the National Academy of Sciences · 1996 · 393 citations · Full text

Histocompatibility, Ctl Lines Specific, Immunology +19

Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development

David J. Kittlesen, Lee W. Thompson, Pamela H. Gulden et al. · The Journal of Immunology · 1998 · 135 citations · Full text

Immunology, Antigen Processing, Immunotherapeutics +16

A Listeria monocytogenes Pentapeptide Is Presented to Cytolytic T Lymphocytes by the H2-M3 MHC Class Ib Molecule

Pamela H. Gulden, Philip Fischer, Nicholas E. Sherman et al. · Immunity · 1996 · 111 citations · Full text

Mass‐spectrometric evaluation of HLA‐A*0201‐associated peptides identifies dominant naturally processed forms of CTL epitopes from MART‐1 and gp100

Jonathan Skipper, Pamela H. Gulden, Ronald C. Hendrickson et al. · International Journal of Cancer · 1999 · 95 citations